Onset of AHC typically occurs within the first 18 months of life and has been associated with mutations, usually occurring de novo, in the ATP1A3 gene, which encodes the alpha3 subunit of the Na+/K+-ATPase transporter [5]. The gene discussed is ATP1A3; the disease is alternating hemiplegia of childhood.